Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yesafili, a biosimilar of aflibercept, will enhance treatment options for patients suffering from eye conditions like macular degeneration in the European region
The Nifty Pharma index closed 0.51 per cent down at 15503.45.
He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
Biocon appoints Peter Bains as group CEO, effective immediately. Bains has over 30 years of global experience in leadership roles.
The Nifty Pharma index closed 0.26 per cent up at 15489.3.